Artikel ; Online: Characterization of POLE c.1373A > T p.(Tyr458Phe), causing high cancer risk.
Molecular genetics and genomics : MGG
2023 Band 298, Heft 3, Seite(n) 555–566
Abstract: The cancer syndrome polymerase proofreading-associated polyposis results from germline mutations in the POLE and POLD1 genes. Mutations in the exonuclease domain of these genes are associated with hyper- and ultra-mutated tumors with a predominance of ... ...
| Abstract | The cancer syndrome polymerase proofreading-associated polyposis results from germline mutations in the POLE and POLD1 genes. Mutations in the exonuclease domain of these genes are associated with hyper- and ultra-mutated tumors with a predominance of base substitutions resulting from faulty proofreading during DNA replication. When a new variant is identified by gene testing of POLE and POLD1, it is important to verify whether the variant is associated with PPAP or not, to guide genetic counseling of mutation carriers. In 2015, we reported the likely pathogenic (class 4) germline POLE c.1373A > T p.(Tyr458Phe) variant and we have now characterized this variant to verify that it is a class 5 pathogenic variant. For this purpose, we investigated (1) mutator phenotype in tumors from two carriers, (2) mutation frequency in cell-based mutagenesis assays, and (3) structural consequences based on protein modeling. Whole-exome sequencing of two tumors identified an ultra-mutator phenotype with a predominance of base substitutions, the majority of which are C > T. A SupF mutagenesis assay revealed increased mutation frequency in cells overexpressing the variant of interest as well as in isogenic cells encoding the variant. Moreover, exonuclease repair yeast-based assay supported defect in proofreading activity. Lastly, we present a homology model of human POLE to demonstrate structural consequences leading to pathogenic impact of the p.(Tyr458Phe) mutation. The three lines of evidence, taken together with updated co-segregation and previously published data, allow the germline variant POLE c.1373A > T p.(Tyr458Phe) to be reclassified as a class 5 variant. That means the variant is associated with PPAP. |
|---|---|
| Mesh-Begriff(e) | Humans ; DNA Polymerase II/genetics ; DNA Polymerase II/chemistry ; DNA Polymerase II/metabolism ; Poly-ADP-Ribose Binding Proteins/genetics ; Neoplasms/genetics ; Mutation ; Exonucleases/genetics ; Exonucleases/metabolism |
| Chemische Substanzen | N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane (131903-56-5) ; DNA Polymerase II (EC 2.7.7.7) ; Poly-ADP-Ribose Binding Proteins ; Exonucleases (EC 3.1.-) |
| Sprache | Englisch |
| Erscheinungsdatum | 2023-03-01 |
| Erscheinungsland | Germany |
| Dokumenttyp | Journal Article |
| ZDB-ID | 2044817-X |
| ISSN | 1617-4623 ; 1617-4615 |
| ISSN (online) | 1617-4623 |
| ISSN | 1617-4615 |
| DOI | 10.1007/s00438-023-02000-w |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.A 1198: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.